MiR-520b inhibits proliferation, migration and invasion in gallbladder carcinoma by targeting RAB22A

Jianpeng Zhou1, Feng Gao2, Hua Zhang2

  • 1Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin, China.

Abstract

Insights

MicroRNA-520b (miR-520b) suppresses gallbladder carcinoma (GBC) progression by targeting RAB22A. Lower miR-520b and higher RAB22A expression in GBC tissues indicate a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) play crucial roles in cancer development.
  • Previous research indicated miR-520b's tumor-suppressive function in various cancers.
  • The role of miR-520b in gallbladder carcinoma (GBC) remained largely unexplored.

Purpose of the Study:

  • To investigate the functional role of miR-520b in GBC progression.
  • To elucidate the underlying molecular mechanisms of miR-520b action in GBC.
  • To determine the relationship between miR-520b and its potential target, RAB22A, in GBC.

Main Methods:

  • Quantitative real-time PCR (qPCR) for miR-520b and RAB22A mRNA.
  • Western blot and immunohistochemistry (IHC) for RAB22A protein.
  • Cellular assays (MTT, colony formation, wound healing, Transwell) to assess proliferation, colony formation, migration, and invasion.
  • Dual luciferase reporter assay to confirm direct binding of miR-520b to RAB22A 3'-UTR.

Main Results:

  • MiR-520b expression was significantly downregulated in GBC tissues compared to normal tissues.
  • Overexpression of miR-520b inhibited NOZ cell proliferation, colony formation, migration, and invasion.
  • MiR-520b directly targeted RAB22A, as confirmed by luciferase assay.
  • RAB22A overexpression abrogated the anti-tumor effects of miR-520b.
  • RAB22A expression was upregulated in GBC tissues and negatively correlated with miR-520b levels.

Conclusions:

  • MiR-520b exhibits potent suppressive effects on GBC progression.
  • The tumor-suppressive role of miR-520b in GBC is mediated through the direct targeting of RAB22A.
  • MiR-520b represents a potential therapeutic target for GBC treatment.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.6K